Using decision analytic methods to assess the utility of family history tools

American Journal of Preventive Medicine

Volumn 24, Issue 2, 2003, Pages 199-207

  Tyagi, Anupam ^a,c   Morris, Jill ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLORECTAL CARCINOMA; COST; DECISION MAKING; FAMILY HISTORY; HUMAN; PREVENTIVE MEDICINE; PUBLIC HEALTH; QUALITY CONTROL; REVIEW; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

EID: 0037304601     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(02)00594-9     Document Type: Review

References (56)

1. Yoon PW, Scheuner MT, Khoury MJ. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003;24.
2. Hunt S.C., Gwinn M., Adams T.D. Family History Assessment strategies for prevention of cardiovascular disease . Am J Prev Med. 24:2003;136-142.
3. Kardia S.L.R., Modell S.M., Peyser P.A. Family-centered approaches to understanding and preventing coronary heart disease. Am J Prev Med. 24:2003;143-151.
4. Harrison T.A., Hindorff L.A., Kim H., et al. Family history of diabetes as a potential public health tool. Am J Prev Med. 24:2003;152-159.
5. Burke W., Fesinmeyer M., Reed K., Hampson L., Carlsten C. Family history as a predictor of asthma risk. Am J Prev Med. 24:2003;160-169.
6. Keku T.O., Millikan R.C., Martin C., Rahkr-Burris T.K., Sandler R.S. Family history of colon cancer what does it mean and how is it useful? Am J Prev Med. 24:2003;170-176.
7. Bowen D.J., Ludman E., Press N., Vu T., Burke W. Achieving utility with family history colorectal cancer risk . Am J Prev Med. 24:2003;177-182.
8. Audrain-McGovern J., Hughes C., Patterson F. Effecting behavior change awareness of family history . Am J Prev Med. 24:2003;183-189.
9. Ziogas A., Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med. 24:2003;199. 198.
10. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in health and medicine. 1996;Oxford University Press, New York.
11. Haddix A.C., Teutsch S.M., Shaffer P.A., Dunet D.O. Prevention effectiveness A guide to decision analysis and economic evaluation . 1996;Oxford University Press, New York.
12. Aitken J., Bain C., Ward M., Siskind V., MacLennan R. How accurate is self-reported family history of colorectal cancer? Am J Epi. 141:1995;863-871.
13. Glanz K., Grove J., Le Marchand L., Gotay C. Underreporting of family history of colon cancer correlates and implications . Cancer Epidemiol Biomarkers Prev. 8:1999;635-639.
14. Mandelblatt J.S., Fryback D.G., Weinstein M.C., Russell L.B., Gold M.R., Hadorn D.C. Assessing the effectiveness of health interventions. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in health and medicine. 1996;Oxford University Press, New York.
15. Gorsky R.D., Haddix A.C., Shaffer P.A. Cost of an intervention. Haddix A.C., Teutsch S.M., Shaffer P.A., Dunet D.O. Prevention effectiveness A guide to decision analysis and economic evaluation . 1996;Oxford University Press, New York.
16. Luce B.R., Manning W.G., Siegel J.E., Lipscomb J. Estimating costs in cost-effectiveness analysis. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-Effectiveness in health and medicine. 1996;Oxford University Press, New York.
17. Stiglitz J.E. Discount rates the rate of discount for benefit-cost analysis and the theory of the second best . Lind R. Discounting for time and risk in energy policy. 1982;151-204 Resources for the Future, Washington, DC.
18. Dreze J., Stern N. Shadow prices and markets policy reform, shadow prices and market prices . J Public Econ. 42:1990;1-45.
19. Shaffer P.A., Haddix A.C. Time preference. Haddix A.C., Teutsch S.M., Shaffer P.A., Dunet D.O. Prevention effectiveness: a guide to decision analysis and economic evaluation. 1996;Oxford University Press, New York.
20. Lipscomb J., Weinstein M.C., Torrance G.W. Time preference. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in health and medicine. 1996;Oxford University Press, New York.
21. Weinstein M.C., Zeckhauser R. Critical ratios and efficient allocation. J Public Econ. 2:1973;147-157.
22. Johannesson M., Weinstein M.C. On the decision rules of cost-effectiveness analysis. J Health Econ. 12:1993;459-467.
23. Karlsson G., Johannesson M. The decision rules of cost-effectiveness analysis. Pharmacoeconomics. 9:1996;113-120.
24. Hunt S.C., Williams R.R., Barlow G.K. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis. 39:1986;809-821.
25. Williams R.R., Hunt S.C., Heiss G., et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (The Health Family Tree Study and The NHLBI Family Health Study). Am J Cardiol. 7:2001;129-135.
26. Mullahy J., Manning W.G. Statistical issues in cost-effectiveness analysis. Sloan F. Valuing health care: costs, benefits and effectiveness of pharmaceuticals and other medical technologies. 1995;Cambridge University Press, New York.
27. Briggs A., Sculpher M., Buxton M. Uncertainty in the economic evaluation of health care technologies the role of sensitivity analysis . Health Econ. 3:1994;95-104.
28. O'Brian B.J., Drummond M.F., Labelle R.J., Willan A. In search of power and significance Issues in the design and analysis of stochastic cost-effectiveness studies in health care . Med Care. 32:1994;150-163.
29. Briggs A., Sculpher M. Sensitivity analysis in economic evaluation A review of published studies . Health Econ. 4:1995;355-371.
30. Wakker P., Klaassen M.C. Confidence intervals for cost/effectiveness ratios. Health Econ. 4:1995;373-381.
31. Manning W.G., Fryback D.G., Weinstein M.C. Reflecting uncertainty in cost-effectiveness analysis. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-effectiveness in health and medicine. 1996;Oxford University Press, New York.
32. Meltzer D. Addressing uncertainty in medical cost-effectiveness analysis Implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research . J Health Econ. 20:2001;109-129.
33. American Cancer Society. Cancer Facts and Figures, 2002. Atlanta, GA: American Cancer Society, 2002.
34. Tomeo C.A., Colditz G.A., Willett W.C., et al. Harvard Report on Cancer Prevention. Volume 3 Prevention of colon cancer in the United States . Cancer Causes Control. 10:1999;167-180.
35. Potter J.D., Slattery M.L., Bostick R.M., Gapstur S.M. Colon cancer a review of the epidemiology . Epidemiol Rev. 15:1993;499-545.
36. Fuchs C.S., Giovannucci E.L., Colditz G.A., Hunter D.J., Speizer F.E., Willett W.C. A prospective study of family history and the risk of colorectal cancer. New Engl J Med. 331:1994;1669-1674.
37. Whittemore A.S., Wu A.H., Kolonel L.N., et al. Family history and prostate cancer risk in Black, White, and Asian men in the United States and Canada. Am J Epidemiol. 141:1995;732-740.
38. Slattery M.L., Kerber R.A. Family history of cancer and colon cancer risk the Utah Population Database . J Natl Canc Inst. 86:1994;1618-1626.
39. Le Marchand L., Zhao L.P., Quiaoit F., Wilkens L.R., Kolonel L.N. Family history of colorectal cancer in the multiethnic population of Hawaii. Am J Epidemiol. 144:1996;1122-1128.
40. Hemminki K., Vaittinen P., Kyyronen P. Modification of cancer risk in offspring by parental cancer (Sweden). Cancer Causes Control. 10:1999;125-129.
41. Newcomb P.A., Taylor J.O., Trentham-Deitz A. Interactions of familial and hormonal risk factors for large bowel cancer in women. Int J Epidemiol. 28:1999;603-608.
42. Askling J., Dickman P.W., Karlen P., et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease a population-based cohort study . Lancet. 357:2001;262-266.
43. Askling J., Dickman P.W., Karlen P., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterol. 120:2001;1356-1362.
44. Sandhu M.S., Luben R., Khaw K.-T. Prevalence and family history of colorectal cancer implications for screening . J Med Screen. 8:2001;69-72.
45. Scheuner M.T., Wang S.-J., Raffel L.J., Larabell S.K., Rotter J.I. Family history a comprehensive genetic risk assessment method for the chronic conditions of adulthood . Am J Med Genet. 22:(71):1997;315-324.
46. Yoon P.W., Scheuner M.T., Peterson-Oehlke K.L., Gwinn M., Faucett A., Khoury M.J. Can family history be used as a tool for public health and preventive medicine? Genet Med. 4:2002;304-310.
47. Centers for Disease Control and Prevention. Colorectal Cancer The Importance of Prevention and Early Detection. Available at: www.cdc.gov/cancer/colorctl/colorect.htm. Accessed on July 20, 2002.
48. Pignone M., Saha S., Hoerger T., Mandelblatt J. Cost-effectiveness analysis of colorectal cancer screening a systematic review for the U.S. Preventive Services Task Force . Ann Intern Med. 137:2002;E96-E106.
49. Pignone M., Rich M., Teutsch S.M., Berg A.O., Lohr K.N. Screening for colorectal cancer in adults at average risk a summary of the evidence for the U.S. Preventive Services Task Force . Ann Intern Med. 137(2):2002;132-141. Available at: www.ahrq.gov/clinic/3rduspstf/colorectal/colosum1.htm. Accessed on September 10, 2002.
50. Smith R.A., von Eschenbach A.C., Wender R., et al. American Cancer Society guidelines for the early detection of cancer update on early detection guidelines for prostate, colorectal, and endometrial cancers . CA Cancer J Clin. 52:2002;8-22.
51. Screening for colorectal cancer recommendation and rationale . Ann Intern Med. 137:2002;129-131.
52. Trends in screening for colorectal cancer - United States, 1997 and 1999. Morbid Mortal Wkly Rep. 50:2001;162-180.
53. Centers for Disease Control and Prevention. Colorectal Cancer Facts on Screening. Available at: www.cdc.gov/cancer/screenforlife/fs_detailed.htm. Accessed on July 20, 2002.
54. Weinstein M.C., Fineberg H.V. Clinical Decision Analysis. 1980;WB Saunders, Philadelphia.
55. Garber A.M. Advances in cost-effectiveness analysis of health interventions. Culyer A.J., Newhouse J.P. Handbook of health economics, vol 1. 2000;181-221 North-Holland, Amsterdam.
56. Drummond M., McGuire A. Economic evaluation in health care: merging theory with practice. 2001;Oxford University Press, New York.